Payal Rana, MS, MBA, PhD

Director
Pfizer
Groton, Connecticut, United States

Presentation(s):

• Beyond the Conventional Paradigm: Rethinking the Necessity of Chronic Toxicity Studies for Biotherapeutics (S22)

  Wednesday, November 20, 2024
  3:45 PM - 5:00 PM CT

• Industry Perspective of Value of Chronic Toxicity in Identifying Adverse Safety Signal in Human (S22-1)

  Wednesday, November 20, 2024
  3:45 PM - 4:05 PM CT